Clinical trial
Mast-Cell Stabilizing Effects of Olopatadine
NCT00389025 · Alcon Research, Industry · Completed
Key facts
| NCT number | NCT00389025 |
|---|---|
| Title | Mast-Cell Stabilizing Effects of Olopatadine |
| Official title | Mast-Cell Stabilizing Effects of Olopatadine |
| Lead sponsor | Alcon Research, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Allergic Conjunctivitis |
| Intervention type | Drug |
| Interventions | Olopatadine (generic name) |
| Enrollment | 24 |
| Start date | Oct 1, 2006 |
| Primary completion | Apr 1, 2007 |
| First posted | Oct 17, 2006 |
| Last update posted | Nov 22, 2016 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: